NIH to Increase Opioid and Pain Research by $500 Million
A PPM Brief
As part of the federal government’s focus on opioids, the National Institutes of Health (NIH) has announced a funding increase of $500 million to focus on research aimed at opioid misuse, addiction, and pain. The fiscal year 2016 budget of $600 million will grow to $1.1 billion for fiscal 2018.
NIH Director Francis Collins, MD, said in an announcement that the initiative, called Helping to End Addiction Long-term (HEAL), will focus on ways to “reduce over-prescription of opioids, accelerate development of effective non-opioid therapies for pain, and provide more flexible options for treating opioid addiction.”
FDA Commissioner Scott Gottlieb, added “the number of prescriptions being written is still too high,” adding that “in too many cases, addiction still starts with a prescriber’s pen, either directly or indirectly through prescription drugs left over, and acquired or stolen from friends or family members.”
Related Articles
- FDA, AAPM Open Talks on Evidence-Based Opioid Prescribing
- Why Some Patients Require High Dose Opioid Therapy
- Urine Drug Testing as an Evaluation of Risk
- Taking Advantage of the Peripheral Opioid Receptor
- Non-responsive Pain Patients with CYP-2D6 Defect
- Opioid Treatment 10-year Longevity Survey Final Report